Compliance to a Hormone Therapy Regimen in Breast Cancer

CompletedOBSERVATIONAL
Enrollment

178

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

December 31, 2015

Conditions
Breast Cancer
Interventions
BEHAVIORAL

compliance monitoring

To examine the relationship between adherence to endocrine therapy and variables from the Health Belief Model (i.e., perceived risk, barriers to and benefits of adherence, and cues to action such as physician recommendation) as well as measures of patient's perceptions of patient- and family-centered care in women with estrogen receptor-positive stage I-IIIA breast cancer.

OTHER

medical chart review

Patient's medical records are reviewed for information about the time since diagnosis, tumor characteristics, treatment, and comorbidity.

OTHER

questionnaire administration

Patients complete a 15 minute questionnaire on-line or by mail comprising questions of demographic and medical variables (i.e., age, race/ethnicity, marital and educational status, and medication side effects) as well as health beliefs and selected aspects of patient- and family-centered care. Data collected from the questionnaire will be stored in an Excel database.

Trial Locations (1)

44106

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00666822 - Compliance to a Hormone Therapy Regimen in Breast Cancer | Biotech Hunter | Biotech Hunter